Over nineteen million United States citizens are expected to have cancer by the year 2024, that is almost forty percent of the United State’s expected adult population with a diagnosis within their lifetime. Eric Lefkofsky’s wife Liz is one of those who received the diagnosis, in her case it was breast cancer. It was after witnessing the problems in the industry that held her life in the balance that Lefkofsky co-founded Tempus.
Tempus will act as an operating system for cancer care and possibly patient care in general as time goes on. Tempus wants to make cancer care data-driven and e-enabled by changing the way patient information is accessed, what type is included, and how that information is used on a global scale. By implementing the vision of Tempus, potential cures for cancer and other diseases could be just a batch of compiled data away in the near future.
Lefkofsky wants cancer care to be managed on a molecular level, mainly by including an individual’s complete genome as part of their medical data. This information can be used to pair them with the best treatments available in real-time, which will be updated continuously across the globe. With this information, Tempus and Eric Lefkofsky hope to collect the data that could link to cures and more effective treatments.
Eric Lefkofsky graduated in 1991 with high honors from the University of Michigan and received his Juris Doctor two years later from their law school. Despite this, be chose to jump into the tech field and has co-founded several tech related companies including Groupon. While once the CEO of Groupon, Lefkofsky stepped down from this position to chairman to put more time into other projects like Tempus.
Lefkofsky and wife Liz also run the Lefkofsky Foundation which has assisted over fifty organizations across the world financially. One million, five hundred thousand, and two hundred fifty thousand dollars were donated by the Lefkofsky’s to the Robert H. Lurie Comprehensive Cancer Center, gastric cancer research at Stanford University, and New York’s Weill Cornell Medicine for breast cancer research, respectively. He is also serves as Trustee at Chicago’s Lurie Children’s Hospital.